$0.25
+0.01 (+2.94%)
Open$0.25
Previous Close$0.24
Day High$0.26
Day Low$0.24
52W High$13.80
52W Low$0.18
Volume—
Avg Volume4.70M
Market Cap7.50M
P/E Ratio—
EPS$-9.85
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.42M | 3.23M | 3.00M |
| Net Income | -386,907 | -351,594 | -373,147 |
| Profit Margin | -11.3% | -10.9% | -12.5% |
| EBITDA | -622,705 | -634,407 | -526,103 |
| Free Cash Flow | -366,603 | -274,517 | -229,625 |
| Rev Growth | +21.7% | +15.6% | +5.5% |
| Debt/Equity | 0.38 | 0.31 | 0.42 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |